Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)


Background: Numerous patient-based studies have highlighted the protective role of immunoglobulin E-mediated allergic diseases on glioblastoma (GBM) susceptibility and prognosis. However, the mechanisms behind this observation remain elusive. Our objective was to establish a preclinical model able to recapitulate this phenomenon and investigate the role of immunity underlying such protection. Methods: An immunocompetent mouse model of allergic airway inflammation (AAI) was initiated before intracranial implantation of mouse GBM cells (GL261). RAG1-KO mice served to assess tumor growth in a model deficient for adaptive immunity. Tumor development was monitored by MRI. Microglia were isolated for functional analyses and RNA-sequencing. Peripheral as well as tumor-associated immune cells were characterized by flow cytometry. The impact of allergy-related microglial genes on patient survival was analyzed by Cox regression using publicly available datasets. Results: We found that allergy establishment in mice delayed tumor engraftment in the brain and reduced tumor growth resulting in increased mouse survival. AAI induced a transcriptional reprogramming of microglia towards a pro-inflammatory-like state, uncovering a microglia gene signature, which correlated with limited local immunosuppression in glioma patients. AAI increased effector memory T-cells in the circulation as well as tumor-infiltrating CD4+T-cells. The survival benefit conferred by AAI was lost in mice devoid of adaptive immunity. Conclusion: Our results demonstrate that AAI limits both tumor take and progression in mice, providing a preclinical model to study the impact of allergy on GBM susceptibility and prognosis, respectively. We identify a potentiation of local and adaptive systemic immunity, suggesting a reciprocal crosstalk that orchestrates allergy-induced immune protection against GBM.

Original languageEnglish
JournalAllergy: European Journal of Allergy and Clinical Immunology
Early online date18 Oct 2022
Publication statusE-pub ahead of print - 18 Oct 2022


  • glioma-induced immunosuppression
  • immunoglobulin-E
  • microglia
  • T-lymphocytes
  • tumor microenvironment


Dive into the research topics of 'Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice'. Together they form a unique fingerprint.

Cite this